| 中国医疗不良事件报告与质量改进的分析研究 |
| |
| 引用本文： | 王吉善陈晓红王圣友张艳丽赵娜孙辉孙佳璐王莹.中国医疗不良事件报告与质量改进的分析研究[J].中国卫生质量管理,2020,0(6):028-32. |
| |
| 作者姓名： | 王吉善陈晓红王圣友张艳丽赵娜孙辉孙佳璐王莹 |
| |
| 作者单位： | 国家卫生健康委医院管理研究所 |
| |
| 摘 要： | 文章分析了来自国家卫生健康委员会医政医管局收集的82万例不良事件报告中最常见的三项错误，该三项错误占82万例不良事件的53％；还介绍了抽样医院主动报告的五类不良事件，以及国家药品不良事件反应网络监测中心的药品与器械不良事件报告。介绍了北京中卫云医疗数据分析与应用研究院100万例误诊报告的简要内容，简要列举了6个典型误诊病例。介绍了中国政府主要的质量政策以及通过医院评审工作落实政策，改善医院管理的做法，引用《柳叶刀》杂志对中国医疗状况的评价，说明质量政策与医院评审对提升医疗服务安全质量是有效的。同时指出要警惕新发疾病，减少误诊，关注新技术、新材料、新药品应用时可能出现新的不安全事件，以实现高质量发展的目标。
|
| 关 键 词： | 医疗质量 不良事件报告 质量改进 不良反应监测 政策 |
Analysis and Research on Reporting and Quality Improvement of Medical Adverse Events in China |
| |
| WANG Jishan,CHEN Xiaohong,WANG Shengyou,et al.Analysis and Research on Reporting and Quality Improvement of Medical Adverse Events in China[J].Chinese Health Quality Management,2020,0(6):028-32. |
| |
| Authors: | WANG Jishan CHEN Xiaohong WANG Shengyou |
| |
| Affiliation: | National Institute of Hospital Administration,NHC |
| |
| Abstract: | The article described the three most common errors in the 820 000 adverse event reports collected by the Medical Administration and Hospital Administration of the National Health Commission. These three errors accounted for 53% of the 820 000 adverse events.It also introduced the five types of adverse events reported actively by the sample hospitals, and the adverse drug and device adverse event reports of the National Adverse Drug Event Response Network Monitoring Center. The brief content of the 1 million misdiagnosis report of Beijing Zhongwei Cloud Medical Data Analysis and Application Research Institute was introduced, and six typical misdiagnosis cases were briefly listed. It introduced the main quality policies of the Chinese government and the implementation of policies through hospital review work to improve hospital management practices, citing the Lancet Magazine’s evaluation of China’s medical conditions, showing that quality policies and hospital reviews are effective in improving the safety and quality of medical services. At the same time, it was pointed out that we must be alert to new diseases to reduce misdiagnosis, and pay attention to new unsafe incidents when new technologies, new materials, and new drugs are used to achieve the goal of high-quality development. |
| |
| Keywords: | Medical Quality Adverse Event Reporting Quality Improvement Adverse Reaction Monitoring Policy |
|
| 点击此处可从《中国卫生质量管理》浏览原始摘要信息 |
|
点击此处可从《中国卫生质量管理》下载全文 |
